All Products
  • Antibodies
  • 试剂盒
  • 多肽
  • 探针
  • 蛋白
  • 生化试剂
  • 组织芯片
CH
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
抗体药类似物
Path：Home > Products > Antibodies > 抗体药类似物
Products
Products
Research Grade Vunakizumab
All
  • Catalog： TD-HS856046
  • Clonality： mAb
  • Application： Research Grade Biosimilar
  • Synonyms： SHR-1314, CAS: 1792181-33-9
  • Specification：
    1mg
  • Prices：
    ¥询价
Customized service consulting
Information
FAQ
Experimental program
Related Products
Bibliography

Research Grade Vunakizumab

Catalog No. TD-HS856046
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q16552
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names SHR-1314, CAS: 1792181-33-9
Background Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody that targets IL-17A and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis.
Note For research use only. Not suitable for clinical or therapeutic use.